| Search | |
Survey
Should regulation of direct to consumer genetic testing be increased?BioFact:
(1997) - Battelle predicts Genetaceuticals, the combination of genetic research & pharmaceutical needs will foster an explosion over the next decade in the pharmaceutical industry.
HDMA’s Looking Forward in Reverse Logistics Healthcare Seminar - Sept. 22-23 - Dallas, TX
Info.Resource Advisory Board
Publisher of MinnesotaLifeScience.com
Info.Resource works very closely with partnering industry associations, its industry subgroups (e.g. human resource professionals, facility and health/safety managers, regulatory and clinical affairs professionals, etc.), and their member firms. Info.Resource also works closely with a formal advisory board comprised of individuals from industry, industry associations and educational community.
Info.Resource Advisory Board Members:
- Jack Faris, President
Washington Biotechnology & Biomedical Association
- Doug Getter, Executive Director
Iowa Biotechnology Association
- Erik D. Laursen, Director of Business Development
CMC Biopharmaceuticals A/S
- Janice M. LeCocq, Partner
Collins Mabry & Co., L.L.C.
- J. Thomas Ranken, CEO
Vizx Labs, LLC
- Lenny Van Pelt, Founder and Attorney-At-Law
International Patient Advocacy Association
For additional information, please contact:
Philip Ness, President & CEO
Info.Resource, Inc.
Phone: 800.709.8907
E-mail: pbness@InfoResource.org
